Editas Medicine, Inc.

LSE:0IFK Stock Report

Market Cap: US$99.9m

Editas Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0IFK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Dec 24SellUS$1,124Baisong MeiIndividual541US$2.08
03 Dec 24SellUS$3,361Gilmore O’NeillIndividual1,618US$2.08
04 Sep 24SellUS$5,325Gilmore O’NeillIndividual1,555US$3.42
04 Sep 24SellUS$1,774Baisong MeiIndividual518US$3.42
25 Jul 24SellUS$64,370Linda BurklyIndividual11,886US$5.42
19 Jul 24SellUS$34,456Baisong MeiIndividual6,619US$5.21
04 Jun 24SellUS$2,808Baisong MeiIndividual511US$5.50
04 Jun 24SellUS$66,997Gilmore O’NeillIndividual12,191US$5.50
20 May 24SellUS$125,404Erick LuceraIndividual22,337US$5.61
13 May 24BuyUS$253,868Jessica HopfieldIndividual45,000US$5.64
05 Mar 24SellUS$732,884Gilmore O’NeillIndividual77,824US$9.42
04 Mar 24SellUS$191,425Baisong MeiIndividual20,327US$9.42

Insider Trading Volume

Insider Buying: 0IFK insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0IFK?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders326,0950.395%
VC/PE Firms4,900,3345.94%
General Public25,955,37131.4%
Institutions51,366,29962.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 54.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.72%
BlackRock, Inc.
8,024,709US$9.7m3.11%no data
8.09%
The Vanguard Group, Inc.
6,679,606US$8.1m-16.8%no data
5.94%
Deep Track Capital, LP
4,900,334US$5.9m-18.3%0.21%
4.06%
Millennium Management LLC
3,350,856US$4.1m36.2%no data
2.98%
State Street Global Advisors, Inc.
2,462,022US$3.0m-46.4%no data
2.75%
Dimensional Fund Advisors LP
2,267,110US$2.7m-3.32%no data
2.29%
Geode Capital Management, LLC
1,887,696US$2.3m-3.97%no data
1.77%
Avidity Partners Management, L.P.
1,465,000US$1.8m79.5%0.11%
1.65%
Two Sigma Investments, LP
1,358,589US$1.6m151%no data
1.58%
UBS Asset Management AG
1,308,142US$1.6m5.18%no data
1.4%
Pictet Asset Management Limited
1,155,937US$1.4m-19%no data
1.37%
Two Sigma Advisers, LP
1,129,000US$1.4m31.8%no data
1.27%
Morgan Stanley, Investment Banking and Brokerage Investments
1,046,890US$1.3m25.7%no data
1.09%
Woodline Partners LP
900,421US$1.1m-7.22%0.01%
1.05%
Jane Street Group, LLC, Asset Management Arm
863,764US$1.0m198%no data
0.98%
Bank of America Corporation, Asset Management Arm
808,610US$978.4k53.8%no data
0.88%
Point72 Asset Management, L.P.
727,132US$879.8k0%no data
0.88%
JP Morgan Asset Management
725,311US$877.6k-3.86%no data
0.85%
Northern Trust Global Investments
703,799US$851.6k-4.55%no data
0.77%
Goldman Sachs Group, Investment Banking and Securities Investments
635,701US$769.2k-3.1%no data
0.76%
Stifel Asset Management Corp.
624,876US$756.1k37.9%no data
0.75%
Charles Schwab Investment Management, Inc.
617,280US$746.9k-15.8%no data
0.68%
Raymond James Financial Inc., Asset Management Arm
561,371US$679.3k6.56%no data
0.65%
Kennedy Capital Management LLC
540,135US$653.6k307%0.02%
0.64%
Goldman Sachs Asset Management, L.P.
531,493US$643.1k-5.54%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 12:16
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Editas Medicine, Inc. is covered by 34 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Joel BeattyBaird
Huidong WangBarclays